Search company, investor...
Verio company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Acquired | Acquired

Total Raised




About Verio

Verio was co-founded by Centennial Ventures to build a successful Internet access and service company through a national consolidation of regional Internet service providers (ISPs). Centennial Ventures led the analysis of an early consolidation opportunity, developed an acquisition model and strategic financing plan, formed the company and attracted the management team. Verio aims to deliver connectivity and a range of Internet applications to small and mid-sized businesses and institutional customers. During a three-year period, Verio integrated over 30 ISPs under its national banner covering 41 of the top 50 MSAs in the U.S. Verio subsequently expanded its strategy to focus on enhanced Internet-based services. Prior to its merger with NTT at a $5.5 billion valuation, Verio was a Web hosting company in the world.

Verio Headquarters Location

8300 E Maplewood Ave Suite 400

Englewood, Colorado, 80111,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Verio News

08:05 EDT LifeScan Presents Real-World Findings Showing Significantly Improved Glycemic Control in People Using OneTouch Verio F...

Jun 6, 2022

News provided by Share this article Patient-generated real-world data from over 120,000 people with diabetes >20 minutes per week on the OneTouch Reveal® app significantly improved blood glucose readings in range in people with type 2 diabetes by 10% MALVERN, Pa., June 6, 2022 /PRNewswire/ -- LifeScan , a world leader in blood glucose monitoring, today announced the presentation of new real-world evidence from patient-generated data showing significantly improved readings in range and lower mean glucose in people using the OneTouch Verio Flex® blood glucose meter with the OneTouch Reveal® mobile application – the late-breaking abstract was presented at the 82nd Scientific Sessions of the American Diabetes Association (ADA) in New Orleans (Abstract Poster 60-LB). GRAPH: OneTouch Reveal App engagement & glycemic improvements (sessions and time) "The insights provided through our retrospective analysis of patient-generated real-world data demonstrate a significant improvement in blood glucose readings in range in those using the OneTouch Verio Flex meter and OneTouch Reveal app," said Dr. Elizabeth Holt, Head of Global Medical, Clinical, and Safety, LifeScan. "These improved readings in range findings are important as 95% of people with diabetes who rely on glucose testing use a blood glucose meter. "  Researchers examined anonymized blood glucose readings with app analytics from a LifeScan data-lake of 100,650 people with type 2 diabetes (T2D) and 20,324 people with type 1 diabetes (T1D), comparing data from their first 14 days to 14 days prior to a 90-day timepoint using paired within-subject differences. Important findings from the study include: Percentage glucose readings in range (70-180mg/dl) improved by 8.7% (from 69.9 to 78.5%) in T2Ds and by 4.0% (from 56.1 to 60.1%) in T1Ds. Hyperglycemic readings (>180mg/dl) reduced by -8.8% (from 28.4 to 19.7%) in T2Ds and by -4.3% (from 38.4 to 34.0%) in T1Ds. Mean glucose reduced on average by -14.1mg/dl (from 160.6 to 146.5mg/dl) in T2Ds and by -6.7mg/dl (from 176.7 to 170.1mg/dl) in T1Ds. 4 to 10 sessions or >20 to 60 minutes per week on the OneTouch Reveal app improved readings in range in T2Ds by 9% or 10%, respectively (see GRAPH). About LifeScan LifeScan is a global leader in blood glucose monitoring and digital health technology and has a vision to create a world without limits for people with diabetes and related conditions. More than 20 million people and their caregivers around the world count on LifeScan's OneTouch brand products to manage their diabetes. Together, LifeScan and OneTouch improve the quality of life for people with diabetes with products and digital platforms defined by simplicity, accuracy, and trust. and SOURCE Lifescan, Inc.

  • When was Verio founded?

    Verio was founded in 1996.

  • Where is Verio's headquarters?

    Verio's headquarters is located at 8300 E Maplewood Ave, Englewood.

  • What is Verio's latest funding round?

    Verio's latest funding round is Acquired.

  • How much did Verio raise?

    Verio raised a total of $18M.

  • Who are the investors of Verio?

    Investors of Verio include NTT Communications, Norwest Venture Partners, Bessemer Venture Partners, Boston Millennia Partners and Centennial Ventures.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.